Tuberöse Sklerose: Pathogenese, Klinik und neue Therapieansätze
Andreas L. Serra(Klinik Hirslanden), Patricia Dill(University of Basel), Thomas Dorn, Patrick Roth(University Hospital of Zurich), Daniel G. Fuster(University of Bern), Günther F.L. Hofbauer(University of Zurich), Benoît Jenny(Hôpital Beau-Séjour), Raphaël Guzman(University of Basel), Barbara Plecko(Graz University Hospital), Maja Steinlin(University Hospital of Bern), Lisa Weibel(University Children's Hospital Zurich), Christian Kätterer, Gabriele Wohrab(University Children's Hospital Zurich), Sarah Bürki(University Hospital of Bern), Olivier Bonny
Cited by 0
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutations
|Human Mutation|2008|429
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
|Orphanet Journal of Rare Diseases|2015|345